Navigation Links
Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
Date:12/28/2007

status. At that time, Immtech and the independent experts in liver toxicity will prepare a summary of the available safety data and recommendations for presentation to the FDA. The clinical hold may be released after FDA has received satisfactory data regarding the safety of pafuramidine.

In return for the commercialization rights to pafuramidine, Par paid Immtech an initial payment of $3 million, which Par incurred as Research & Development (R&D) expense in 2007. Should pafuramidine advance through its ongoing Phase III clinical trials and U.S. regulatory review and approval, Par will pay Immtech up to $29 million in development milestones.

Loramyc(R) (miconazole Lauriad(R)) for the treatment of oropharyngeal candidiasis:

In July 2007, Par Pharmaceutical, Inc. entered into an exclusive licensing agreement under which Par received commercialization rights in the U.S. to BioAlliance Pharma's Loramyc(R) (miconazole Lauriad(R)). Loramyc(R) is an innovative antifungal therapy in Phase III development for the treatment of oropharyngeal candidiasis, an opportunistic infection commonly found in immunocompromised patients, including those with HIV and cancer.

Loramyc(R), which received marketing authorization in France in October 2006, is an antifungal delivered in a mucoadhesive buccal tablet, enabling an early and extended release of the active ingredient at the site of infection, with once-daily dosing.

Patient enrollment has been completed in the pivotal Phase III clinical trial intended to support U.S. registration. Trial results are expected in the first half of 2008 and a new drug application is expected to be submitted to FDA in the second half of 2008.

In return for the commercialization rights to Loramyc(R), Par paid BioAlliance an initial payment of $15 million, which Par incurred as R&D expense in 2007. Upon FDA approval of the product, Par will also pay BioAlliance $20 million. In addition to royalties on sales, BioAll
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Introducing Strativa Pharmaceuticals
2. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
3. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
4. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
5. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
6. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
7. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
8. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
9. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
10. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Cystic fibrosis (CF) is a genetic ... gastrointestinal organs. In particular, very thick mucus accumulates in ... difficult to clear, occludes the airways, and creates an ... frequently suffer from chronic biofilm infections, and ultimately succumb ... approach to treating the major challenges in the lungs ...
(Date:10/2/2014)... Mich. (PRWEB) October 02, 2014 MS ... with Hile Creative to refine its marketing approach. Backed ... MS Bioworks serves researchers in the biological sciences, including ... Bioworks has already seen substantial growth over the past ... with current customers, the company plans to launch a ...
(Date:10/2/2014)... (PRWEB) October 02, 2014 At a time ... Bel-Art Products has introduced a new kind of squeeze ... market is the Scienceware® Squeeze Rite™ Wash Bottle , ... tube position within the bottle reduces the waste of reagents, ... of those liquids. , “Easier to squeeze when compared to ...
(Date:10/2/2014)... CARLOS, Calif. and BRIDGEWATER, ... Corporation (NYSE: XON) , a leader in synthetic ... seventh largest generic drug manufacturer by volume in ... second Exclusive Channel Collaboration (ECC) for a target ... expression system, the goal of the collaboration is ...
Breaking Biology Technology:Synedgen to Present at North American Cystic Fibrosis Conference 2Synedgen to Present at North American Cystic Fibrosis Conference 3Hile Creative to Provide Copywriting and Graphic Design Services for MS Bioworks 2New Wash Bottle Reduces Waste of Reagents, Solutions, and Other Liquids 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 3
... Wis . - The Medical College of Wisconsin ... National Institute of Neurological Disorders and Stroke ... , ,The research, which will be led by principal ... examine the link between oxygen deficit and loss of ...
... Green Bay, Wis. - For six years, Steve Matheys served ... experience during that period - 1998 to 2004 - convinced him ... for bigger and better things in the executive suite. , ,Provided ... is. , ,Matheys, who now serves as executive vice president of ...
... Milwaukee, Wis . - He is fast becoming one of ... and if he has his way chief information officers and ... when they move to fill IT staff openings. , ... during the Wisconsin Entrepreneur's Conference in Milwaukee, is ...
Cached Biology Technology:Visions: Matheys says CIO role is good training for executive suite 2Visions: Matheys says CIO role is good training for executive suite 3Visions: Matheys says CIO role is good training for executive suite 4Jump starting technology education 2Jump starting technology education 3
(Date:9/30/2014)... farm runoff in Hawaii is causing tumors in endangered ... study, published Tuesday in the peer-reviewed open-access journal ... up in algae that the turtles eat, promoting the ... internal organs. , Scientists at Duke University, the University ... (NOAA) conducted the study to better understand the causes ...
(Date:9/30/2014)... Munich report that a new class of chemical ... drugs. They have also pinpointed the relevant target ... agents. , Researchers led by LMU,s Professor ... Technische Universitt Mnchen have identified a class of ... the fight against malignant tumors. The compound is ...
(Date:9/30/2014)... pregnanteven with IVF? Here,s some hope: A new research ... The FASEB Journal , explains how scientists developed ... PAWP, which induced embryo development in human and mouse ... by the sperm cell during fertilization. , "We believe ... paradigm shift in our understanding of human fertilization by ...
Breaking Biology News(10 mins):Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Cancer therapy: Driving cancer cells to suicide 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2
... dinner fat intake seem to influence negatively the sleep pattern ... be presented on Tuesday at SLEEP 2008, the 22nd Annual ... study, authored by Cibele Crispim, of the Federal University of ... 20-45 years of age, whose food intake was analyzed by ...
... forensic scientists at the University of Copenhagen has studied human ... to the iron age, and discovered a man who appears ... beings were as genetically diverse 2000 years ago as they ... than was previously thought. The findings also suggest that people ...
... A new book, Grounds for Knowledge , ... modern buildings and the striking landscape that surrounds them. ... L. Watson, who, together with her husband James D. Watson ... picturesque grounds of CSHL for almost four decades. The ...
Cached Biology News:Fat intake negatively influences the sleep pattern in healthy adults 2New research refutes myth of pure Scandinavian race 2New research refutes myth of pure Scandinavian race 3
Request Info...
... Universal Amplicon Detection Assay (ADA) ... the qualitative detection and quantitation ... in vitro nucleic acid amplification. ... to be used in diagnostic ...
{3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide}. ,250 ug/ml Propidium Iodide (PI) in PBS....
... DNAzol Reagents are complete ready-to-use reagents for ... Reagent is specifically formulated for the isolation ... Reagent is specifically formulated for the isolation ... isolated with DNAzol Reagents can be used ...
Biology Products: